Se-cure Pharmaceuticals

Company Overview

Snapshot

Founded in March 1997, Se-cure Pharmaceuticals operates with 11–50 employees. The company has raised $14 million across one funding round from 5 investors. In December 2017, Se-cure Pharmaceuticals launched a new women's supplement line in the U.S.

Business overview

Se-cure Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing therapeutic solutions derived from botanical sources. The company utilizes proprietary botanical drug development and scaling technologies to introduce novel biochemical agents with selective mechanisms of action. Its methodology aligns with US FDA botanical drug development guidelines, establishing human and post-marketing data through over-the-counter pilot sales. Se-cure Pharmaceuticals serves the health tech and life sciences sector, with a pipeline targeting women's health, osteoporosis, men's health, benign hyperplasia, burn injury management, and dental bone rejuvenation.

Strategic signal

In December 2017, Se-cure Pharmaceuticals launched a new women's supplement line in the U.S. This expansion into the American market signals the company's strategic intent to broaden its commercial reach and capitalize on the growing demand for botanical therapeutics in women's health, indicating a focus on product diversification and market penetration.

Company Intelligence Q&A

What is Se-cure Pharmaceuticals' primary focus?

Se-cure Pharmaceuticals is a clinical-stage, technology-driven pharmaceutical company focused on developing safe and effective therapeutic solutions derived from botanical sources.

What is the company's approach to drug development?

Se-cure Pharmaceuticals implements proprietary botanical drug development and scaling technologies to introduce novel biochemical agents. Its methodology for developing drugs from botanical sources is in accordance with US FDA botanical drug development guidelines.

What markets does Se-cure Pharmaceuticals target?

Se-cure Pharmaceuticals' current pipeline includes six botanical drug candidates whose targets include women's health and osteoporosis management, men's health and benign hyperplasia management, burn injury management, and dental bone rejuvenation.

When did Se-cure Pharmaceuticals launch a new women's supplement line in the U.S.?

In December 2017, Se-cure Pharmaceuticals launched a new women's supplement line in the U.S.

Has Se-cure Pharmaceuticals sought a public listing?

In April 2014, Se-cure Pharmaceuticals sought a Wall Street listing.